was inadvertently switched during the revision process with a previously published figure (1) showing results on B16 melanoma cells. The correct figure, summarizing the results on human MeWO melanoma cells transfected with ␣1,3-fucosyltransferase (FTIII), appears below. We apologize for any confusion caused by this mistake.
D
istinct cell-surface carbohydrates are expressed in tissueand cell-specific manners during development and in adulthood. Aberrations in cell-surface carbohydrates often are associated with malignant transformation and other pathological conditions (1) (2) (3) . Among various cell-type-specific carbohydrates, sialyl Lewis x, NeuNAc␣233Gal␤134(Fuc␣133) GlcNAc␤3R, is expressed on neutrophils, monocytes, and certain T lymphocytes (4, 5) and plays a key role in the recruitment of leukocytes. E-and P-selectin expressed on activated endothelial cells capture these leukocytes through binding to sialyl Lewis x, allowing them to roll, which leads to extravasation of leukocytes at inflammatory sites (6, 7) . Lymphocyte circulation is directed by interaction between L-selectin on lymphocytes and the sulfated form of sialyl Lewis x present on L-selectin receptors that are restricted to high endothelial venules (8) (9) (10) . Such an initial interaction leads to extravasation of lymphocytes from the intravascular compartment to the lymphatic compartment.
The amounts of sialyl Lewis x and sialyl Lewis a, NeuNAc␣233Gal␤133(Fuc␣133)GlcNAc3R, which also has been shown to bind to E-selectin (11, 12) , are increased significantly in tumor cells such as carcinoma and leukemia (13) (14) (15) (16) . In breast and colonic carcinoma patients, the presence of sialyl Lewis x and sialyl Lewis a is correlated with poor prognosis (17) (18) (19) . These results strongly suggest that blood-borne tumor cells may use a carbohydrate-selectin (or a selectin-related molecule) interaction when tumor cells adhere to the endothelia at metastatic sites. In fact, we have shown recently that B16 melanoma cells become highly metastatic when they express moderate amounts of sialyl Lewis x as a result of transfection of ␣1,3-fucosyltransferase III (FTIII) (20) . Similarly, a lung carcinoma cell line becomes highly metastatic after transfection of fucosyltransferase VII, which directs expression of increased amounts of sialyl Lewis x (21). These results indicate that sialyl Lewis x (or sialyl Lewis a) plays a direct role in metastasis. During our studies of B16 melanoma cells, we also discovered that B16 melanoma cells overexpressing sialyl Lewis x, B16-FTIII⅐H cells, were not tumorigenic in wild-type mice but were highly tumorigenic in beige mice, which have defective natural killer (NK) cells (20) . The studies, however, did not determine whether B16 melanoma cells expressing high levels of sialyl Lewis x can be directly targeted by NK cells.
The above studies also suggest that tumor dissemination may be inhibited by use of sialyl Lewis x oligosaccharides as antagonists. To test this hypothesis, a peptide-displaying phage library was screened for peptides binding to E selectin (22, 23) . Specifically, we screened a peptide-displaying library by using an anti-Le a antibody as a target and isolated peptides that compete with sialyl Lewis x for binding to E-, L-, and P-selectin in a calcium-dependent manner (23) . One of these isolated peptides, IELLQAR, inhibited lung tumor formation by B16 melanoma cells transfected with FTIII or human lung carcinoma cells (23, 24) .
In the present study, we first examined lung tumor formation of human MeWo melanoma cells after transfection with FTIII to allow expression of sialyl Lewis x. We found that MeWo cells expressing moderate amounts of sialyl Lewis x (MeWo-FTIII⅐M) form numerous lung tumor foci. MeWo cells expressing large amounts of sialyl Lewis x (MeWo-FTIII⅐H) were not tumorigenic in nude mice but were highly tumorigenic in beige mice. In vitro assays demonstrated that MeWo-FTIII⅐H cells as well as B16-FTIII⅐H cells are highly susceptible to NK cell-mediated cytotoxicity, whereas MeWo-FTIII⅐M and B16-FTIII⅐M cells are less so. We also showed that the susceptibility of MeWo-FTIII⅐H cells to NK cell-mediated cytolysis can be inhibited by preincubating them with anti-sialyl Lewis x antibody or by adding IELLQAR peptide during the cytotoxicity assay. Moreover, we found that the CD94 receptor on NK cells recognizes sialyl Lewis x expressed on tumor cells.
Materials and Methods
Transfection of MeWo Cells with pcDNA-FTIII. Human MeWo melanoma cells, which are negative for sialyl Lewis x expression as assessed by immunostaining, were transfected with pcDNA3(neo)-FTIII (25) as described (20) . Transfected cells were cultured in RPMI medium 1640 containing 10% (vol͞vol) FCS and G418 (800 g͞ml; GIBCO͞BRL), and single colonies were selected as deThis paper was submitted directly (Track II) to the PNAS office.
Abbreviations: FTIII, ␣1,3-fucosyltransferase III; NK, natural killer; LEA, tomato lectin; DSA, Datura stramonium agglutinin.
scribed (20) . The cells were dissociated into monodispersed cells by using an enzyme-free cell dissociation solution (Hanks' based) purchased from Cell and Molecular Technologies (Phillipsburg, NJ). Monodispersed cells were incubated with anti-sialyl Lewis x antibody (CSLEX-1; Becton Dickinson) followed by FITCconjugated goat affinity-purified F(abЈ) 2 fragments specific to mouse IgM (Cappel). The cells were separated by cell sorting into cells negative for sialyl Lewis x expression (MeWo-FTIII⅐N), cells expressing moderate amounts of sialyl Lewis x (MeWo-FTIII⅐M), and cells strongly positive for sialyl Lewis x (MeWo-FTIII⅐H). B16-FTIII⅐H, B16-FTIII⅐M, and B16-FTIII⅐N were established as described (20) .
Tumor Formation in Mice. The above sorted cell populations were cultured approximately 1 week to obtain a sufficient number of cells. A total of 5 ϫ 10 6 monodispersed cells (Ͼ90% viability) were suspended in 100 l of serum-free RPMI medium 1640 and injected into the tail vein of BALB͞c nude (nu͞nu) or beige mice (C.B-17 scid-beige; 6-8 weeks, female). After 2 (beige mice) or 3 (nude mice) weeks, mice were killed, organs were fixed with Bouin's solution, and tumor foci were counted under a dissecting microscope. Because the majority of tumors occurred in the lung, this organ was selected for evaluation of tumor formation.
Isolation of IELLQAR Peptide That Mimics Sialyl Lewis x.
Peptides mimicking sialyl Lewis x were isolated by screening a peptideharboring phage library by using anti-Lewis a antibody (clone 7LE; ref. 11) as a target molecule as described (23) . IELLQAR, the most potent, calcium-dependent E selectin-binding peptide, and an unrelated VTSIAQA control peptide were synthesized as octameric peptides containing the (Lys) 4 3(Lys) 2 3Lys backbone. To test the inhibitory activity of the IELLQAR peptide on tumor formation, IELLQAR or control peptide (500 g͞100 l per mouse) was injected through a tail vein of a nude mouse. After 20 min, MeWo-FTIII⅐M cells were injected into a second tail vein and tumor formation was assessed as described above.
Preparation of NK Cells. NK cells were purified from human peripheral blood essentially as described (26) . Briefly, human peripheral mononuclear cells were obtained by using a Ficoll͞Paque cushion and then passed through a nylon wool column (Wako Pure Chemical, Osaka) to remove adherent cells. To obtain IL-2-activated NK cells (26), 1 ϫ 10 6 per ml of the cells prepared above were cultured in RPMI medium 1640 containing 10% (vol͞vol) FCS, 2 mM L-glutamine, and 1 mM sodium pyruvate in the presence of 1,000 units͞ml of IL-2 (Cetus) for 3 days. Mouse NK cells were isolated from spleens of C57BL͞6 and nude mice and activated by IL-2 as described (26) .
Cytotoxicity Assay. Cytotoxicity was measured by using the CytoTox96 Nonradioactive Cytotoxicity Assay kit (Promega). This assay is based on the release of lactate dehydrogenase from lysed cells. All assays were performed in triplicate. Percent cytotoxicity ϭ (experimental lactate dehydrogenase release Ϫ effector spontaneous release Ϫ target spontaneous release) Ϭ (target maximum release Ϫ target spontaneous release) ϫ 100. mAb and Peptide Treatment. To assay the inhibition of tumor formation and cytotoxicity by anticarbohydrate antibodies, MeWo-FTIII cells were incubated with anti-sialyl Lewis x antibody (CSLEX-1) or anti-Lewis x antibody (CD15; Immunotech, Westbrook, ME) at a concentration of 10 g͞ml for 30 min at 4°C and then subjected to assays for tumor formation or cytotoxicity as described above. To analyze inhibition of cytotoxicity by peptides, the IELLQAR peptide or the control VTSIAQA peptide was added at 10 M or 50 M to the cytotoxicity assay mixture. Similarly, sialyl Lewis x oligosaccharides attached to polyacrylamide gel containing 30% or 10% mole of sialyl Lewis x (GlycoTech, Williamsport, PA; ref. 27 ) was added at 50 M to the cytotoxic assay mixture. To determine which NK cell receptors bind to sialyl Lewis x, anti-L-selectin antibody (PharMingen; ref. MeWo-FTIII⅐N, MeWo-FTIII⅐M, and MeWo-FTIII⅐H cells were metabolically labeled with [ 3 H]galactose, and glycopeptides were prepared as described (31) . The glycopeptides were then applied to a ConA-Sepharose column. Glycopeptides unbound to ConASepharose, representing O-glycans and tri-and tetra-antennary N-glycans, were applied to a column of LEA (tomato lectin)-agarose and eluted as described (31, 32) . Tomato lectin binds glycans having three or more N-acetyllactosamine repeats (31) (32) (33) . The glycopeptides unbound to LEA-agarose were applied to a column of Datura stramonium agglutinin (DSA)-agarose as described (31, 32) .
Results

Isolation of MeWo Cells Expressing Different Amounts of Sialyl Lewis
x. To create MeWo cell lines expressing sialyl Lewis x, cells were transfected with FTIII. FTIII is widely distributed in various tissues and directs the expression of both sialyl Lewis x and sialyl Lewis a (25) . Stably transfected MeWo-FTIII cells were subjected to cell sorting with an anti-sialyl Lewis x antibody and fractionated into three groups: those highly positive (MeWo-FTIII⅐H), moderately positive (MeWo-FTIII⅐M), and negative (MeWo-FTIII⅐N) for sialyl Lewis x (Fig. 1A) . After several passages, the cells maintained the phenotypes seen in Fig. 1B . Among these lines, the difference in sialyl Lewis x expression levels is similar to that of sialyl Lewis a (Fig.  1C) . By contrast, there was almost no difference between MeWo-FTIII⅐M and MeWo-FTIII⅐H cells in staining with an anti-Lewis x antibody (Fig. 1D) , ␣2,3-sialic acid-specific (Macchia amurensis) agglutinin, or ␣2,6-sialic acid-specific (S. nigra) agglutinin (Fig. 1E) . MeWo-FTIII⅐M cells, however, showed slightly stronger staining by tomato lectin than did MeWo-FTIII⅐H cells (Fig. 1F) , suggesting (Fig.  2B) . Similarly, preinjection of the IELLQAR peptide, which mimics sialyl Lewis x, inhibited tumor formation by MeWo-FTIII⅐M cells (Fig. 2B) . The most striking result, however, was that MeWo-FTIII⅐H cells produced as few tumor foci as did MeWo-FTIII⅐N cells in nude mice (Fig. 2 A and B) .
Formation of Lung Tumor Foci in Beige Mice.
Our results indicate that the growth rate, measured as described (20) , is almost the same among three different MeWo-FTIII lines. These results thus suggest that MeWo-FTIII⅐H cells may be more susceptible to immune cell attack than MeWo-FTIII⅐M cells. Because tumor formation described above was assayed in nude mice, which are defective in T cell-dependent immune responses, we chose next to examine tumor formation in beige mice, which are deficient in NK cell activity. The results shown in Fig. 2 A and C clearly demonstrate that the number of tumor foci in beige mice is increased after injection of all of the different MeWo-FTIII cell lines, and, yet, the number of tumor foci produced by different MeWo-FTIII cells is directly proportional to the amount of sialyl Lewis x expressed on the cell surface (Fig. 2C) . These results are consistent with the results obtained on B16-FTIII cells (20) . These results strongly suggest that high expression of sialyl Lewis x on the cell surface results in attack by NK cells, and MeWo-FTIII⅐H and B16-FTIII⅐H cells are eliminated during or after the attachment to endothelial cells. (Fig. 3B) . Similarly, mouse NK cells cytolysed MeWo-FTIII cells corresponding to the amount of sialyl Lewis x expressed on the cell surface (Fig. 3C) .
The CD94 Receptor on Human NK Cells Is Responsible for Cytolysis of
MeWo-FTIII⅐H Cells. We then investigated how human NK cells exhibit cytotoxicity for human MeWo-FTIII cells to gain insight into human tumor progression. Fig. 4A illustrates that MeWo-FTIII⅐H cells are most sensitive to NK cell cytotoxicity and the susceptibility of different MeWo-FTIII cells to such cytotoxicity is proportional to the amount of sialyl Lewis x expressed on the cell surface. This cell lysis was inhibited by preincubation of MeWo-FTIII⅐H cells with anti-sialyl Lewis x antibody but not with antiLewis x antibody (Fig. 4B) and by the presence of IELLQAR peptide, which mimics sialyl Lewis x (23), in a dose-dependent manner but not by the control peptide (Fig. 4C) .
We then determined which cell surface receptors on NK cells, containing a lectin-like domain, are involved in recognition of sialyl Lewis x overexpressed on tumor cells. First, we found that anti-CD94 but not anti-CD69 or anti-L-selectin can inhibit NK cellmediated cytolysis of MeWo-FTIII⅐H cells (Fig. 4D) . Second, we showed that sialyl Lewis x oligosaccharides attached to polyacrylamide gel can inhibit the same NK cell-mediated cytolysis. The extent of the inhibition was more significant when highly dense sialyl Lewis x polymer was used than when less dense sialyl Lewis x polymer was used (Fig. 4E) . Finally, we found that simultaneous addition of anti-CD94 antibody plus sialyl Lewis x oligosaccharide polymer does not result in an additive effect over the addition of anti-CD94 antibody or sialyl Lewis x oligosaccharide polymer alone (Fig. 4F) . These results establish that the CD94 receptor on NK cells recognizes sialyl Lewis x expressed on tumor cells. produced high levels of glycopeptides that bound to and eluted from LEA-agarose (IB in Fig. 5E ). By contrast, fewer glycopeptides from MeWo-FTIII⅐H cells were bound to LEA-agarose (IB in Fig. 5H ). When the glycopeptides unbound to LEA-agarose were applied to DSA-agarose, no significant difference was observed among three MeWo-FTIII cell lines in the amount of glycopeptides bound to DSA-agarose (IA2 in Fig. 5 ). It has been shown that the glycopeptides bound to LEA-agarose contain three or more N-acetyllactosamine repeats, whereas those bound to DSA-agarose include N-glycans containing one or two N-acetyllactosamines (31) (32) (33) . These glycopeptides (IB and IA2 in Fig. 5 ) were then digested with endo-␤-galactosidase before and after defucosylation (34) . These results combined with the results shown in Fig. 1 
MeWo-FTIII⅐M Cells Express
Discussion
The present study provides direct evidence that sialyl Lewis x plays a critical role in tumor metastasis and NK cell-mediated cytolysis. MeWo-FTIII⅐M cells expressing moderate amounts of sialyl Lewis x produced many more lung tumor foci than did the parental MeWo cells or MeWo-FTIII⅐N cells, which express negligible amounts of sialyl Lewis x. Furthermore, preincubation with anti-sialyl Lewis x antibody or preinjection of a sialyl Lewis x-mimicking peptide prevented tumor formation by MeWo-FTIII⅐M cells. The most striking discovery in the present study, however, is that overexpression of sialyl Lewis x on tumor cells, as seen in MeWo-FTIII⅐H cells, does not result in tumor formation in nude mice. By contrast, the same MeWo-FTIII⅐H cells produce a large number of tumor foci in beige mice, which have defective NK cells. These results are consistent with our previous findings showing that B16 melanoma cells overexpressing sialyl Lewis x can produce lung tumor foci only in beige mice or in C57BL͞6 mice that have been depleted of NK cells by treatment with anti-asialo-GM1 antibody (20) . Most importantly, the present study extends these findings by demonstrating that NK cells directly lyse B16-FTIII and MeWo-FTIII cells in proportion to the amount of sialyl Lewis x expressed on the cell surface. We demonstrate that NK cell-mediated lysis of MeWo-FTIII⅐H cells can be inhibited by preincubation of MeWo-FTIII⅐H cells with anti-sialyl Lewis x antibody or addition of sialyl Lewis x-mimicking IELLQAR peptide or sialyl Lewis x oligosaccharide polymer during the cytotoxicity assay. These combined results indicate that moderate expression of sialyl Lewis x on tumor cells results in tumor metastasis, whereas expression of high levels of sialyl Lewis x on tumor cells results in cytolysis by NK cells.
The above conclusion is corroborated by experiments in which MeWo-FTIII⅐H cells were analyzed after many passages. After more than 10 passages, MeWo-FTIII⅐H cells tend to lose sialyl Lewis x and are comparable in levels of sialyl Lewis expression to MeWo-FTIII⅐M cells. The resultant cells produce large numbers of tumor foci in nude mice, as do MeWo-FTIII⅐M cells, but are no longer highly susceptible to NK cell-mediated cytolysis (data not shown). These results, taken together, strongly support our conclusion that differences in the level of sialyl Lewis x expression lead to entirely different biological consequences.
Although it has been shown that NK cells can mediate cytolysis of tumor cells (for review, see ref. 35) , ours is a clear-cut demonstration that a particular carbohydrate structure is recognized by NK cells as a cytolytic signal. We found that the CD94 receptor complex on NK cells recognizes sialyl Lewis x overexpressed on MeWo-FTIII. Moreover, we showed that simultaneous addition of anti-CD94 antibody and sialyl Lewis x oligosaccharide polymer did not have an additive inhibitory effect over the addition of either reagent alone. These results indicate that the CD94 receptor is solely responsible for the recognition of sialyl Lewis x overexpressed on tumor cells. The CD94 receptor complex can be classified into inhibitory and activating receptors, depending on subunits associated with CD94 (36, 37) . Because anti-CD94 antibody inhibited NK-cell-mediated cytotoxicity toward MeWo-FTIII⅐H cells, it can be concluded that the activating CD94 receptor complex functions in this cytotoxicity; otherwise, anti-CD94 antibody treatment should enhance the cytotoxicity to the tumor cells.
Our structural analysis and cell-surface staining by different lectins indicate that MeWo-FTIII⅐M and MeWo-FTIII⅐H exhibit few differences in the level and composition of cell-surface carbohydrates except that MeWo-FTIII⅐H cells contain more heavily fucosylated short N-glycans than do MeWo-FTIII⅐M cells, whereas MeWo-FTIII⅐M cells contain more poly-N-acetyllactosamine than do MeWo-FTIII⅐H cells. We also have shown that B16-FTIII⅐H cells express more sialyl Lewis x on short N-glycans than do B16-FTIII⅐M cells (20) . These results taken together indicate that dense expression of sialyl Lewis x leads to cytolysis by NK cells.
In conclusion, we have shown that sialyl Lewis x is recognized by CD94 on NK cells. Apparently, CD94 binds more efficiently to sialyl Lewis x densely attached to carrier glycans than to sialyl Lewis x sparsely attached to carrier glycans. By contrast, sparsely or moderately attached sialyl Lewis x facilitates tumor metastasis. These results clearly indicate that the difference in sialyl Lewis x expression leads to entirely different biological consequences, providing a potential carbohydrate-based tumor therapy.
